A clinical study of transdermal contraceptive patch in Thai adolescence women

Journal of the Medical Association of Thailand

Volumn 91, Issue 2, 2008, Pages 137-141

  Piyasirisilp, Rachatapon ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Contraceptive patch; Cycle control; Side effect

Indexed keywords

ETHINYLESTRADIOL PLUS NORELGESTROMIN;

ACNE; ADOLESCENT; ADULT; APPLICATION SITE REACTION; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; BREAST TENDERNESS; CLINICAL TRIAL; CONTRACEPTION; DISEASE SEVERITY; DYSMENORRHEA; FAMILY PLANNING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT COMPLIANCE; PATIENT SAFETY; STUDENT T TEST; VOMITING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGE FACTORS; BLOOD PRESSURE; BODY WEIGHT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DYSMENORRHEA; ETHINYL ESTRADIOL; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; NORGESTREL; OXIMES; THAILAND;

EID: 40949102191     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zieman M. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra). Fertil Steril 2002; 77(2 Suppl 2): S1-2.
2. Burkman RT. The transdermal contraceptive system. Am J Obstet Gynecol 2004; 190(4 Suppl): S49-53.
3. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 2002; 77(2 Suppl 2): S3-12.
4. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77(2 Suppl 2): S13-8.
5. Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 2002; 77(2 Suppl 2): S19-26.
6. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 2002; 77(2 Suppl 2): S27-31.
7. Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril 2002; 77(2 Suppl 2): S32-5.
8. Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 2001; 285: 2347-54.
9. Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001; 98: 799-805.
10. Rubinstein ML, Halpern-Felsher BL, Irwin CE Jr. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health 2004; 34: 395-401.
11. Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC. Transdermal contraception: evaluation of three transdermal norelgestromin/ ethinyl estradiol doses in a randomized, multicenter, dose-response study. Am J Obstet Gynecol 2002; 186: 15-20.
12. White T, Jain JK, Stanczyk FZ. Effect of oral versus transdermal steroidal contraceptives on androgenic markers. Am J Obstet Gynecol 2005; 192: 2055-9.
13. Allen DR, Carey JW, Manopaiboon C, Jenkins RA, Uthaivoravit W, Kilmarx PH, et al. Sexual health risks among young Thai women: implications for HIV/STD prevention and contraception. AIDS Behav 2003; 7: 9-21.
14. Suwanmalee O, Taneepanichskul S. A clinical study of transdermal contraceptive patch in Thai women. J Med Assoc Thai 2006; 89(Suppl 4): S1-4.